SynthesisAdvances in therapy2020

Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis.

Kirsi M Manz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.